Cody A Loy

13PUBLICATIONS
12CO-AUTHORS
Molecular targetsMedical devicesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Industrial molecular engineering of nucleic acids and proteinsProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 12, 2026
From probe to prodrug: immunoproteasome activity as a trigger for disease-selective therapeutics.

|Jul 17, 2026
Two Mechanisms One Molecule: Developing a 'Truly' Bifunctional Degrader Targeting Rpn13 and CRBN.

|May 25, 2026
Control of SIINFEKL Antigen Presentation by the Immunoproteasome.

|Dec 13, 2025
Synthesis of Immunoproteasome N-Degron Prodrugs for Selective Protein Degradation.

Cody A Loy, Timothy J Harris, Darci J Trader

|Oct 13, 2025
From Breakdown to Breakthrough: Immunoproteasomes Could Revolutionize Immunotherapies.

Cody A Loy, Darci J Trader

|Aug 19, 2025
Degradation of Abl Utilizing an Immunoproteasome N-Degron Prodrug.

Cody A Loy, Timothy J Harris, Shawn E Vinogradsky

Pageof 3

Frequent Collaborators

13 joint publications

Darci J Trader

3 joint publications

Shawn E Vinogradsky

2 joint publications

Timothy J Harris

1 joint publications

Callie Fredlender